Literature DB >> 9783346

A multimethod approach to assessing perseverations in schizophrenia patients.

W Perry1, D L Braff.   

Abstract

Perseverations have been associated with frontal lobe impairment and are often observed among schizophrenia patients. We assessed perseverations in schizophrenia patients (N = 71) using the Wisconsin Card Sorting Test (WCST) and a new Rorschach perseveration scale which yields three perseveration scores. We also compared the results of the schizophrenia patients with those of a normal comparison group (N = 71). We found that schizophrenia patients demonstrated a high number of perseverations on both the WCST and the Rorschach perseveration scale when compared to the normal comparison subjects. Among schizophrenia patients, WCST perseverative responses were significantly correlated with Rorschach-derived stuck-in-set perseverations, WAIS-R Vocabulary scores and negative symptom ratings. No significant differences in any of the measures of perseveration were found to be associated with diagnostic subtype. Finally, WCST and Rorschach measures for the schizophrenia and normal comparison participants were entered into a logistic regression. The WCST total errors and the three Rorschach perseveration measures resulted in the correct classification of 89.4% of the total cases, with a sensitivity of 91%, specificity of 91% and positive predictive power of 87.8%. These data provide evidence that perseverative behavior is widely observed in schizophrenia patients using a variety of instruments. The authors discuss the benefit of using multiple measures of perseveration in schizophrenia research.

Entities:  

Mesh:

Year:  1998        PMID: 9783346     DOI: 10.1016/s0920-9964(98)00061-9

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  14 in total

1.  The antisaccade task and neuropsychological tests of prefrontal cortical integrity in schizophrenia: empirical findings and interpretative considerations.

Authors:  Deborah L Levy; Nancy R Mendell; Philip S Holzman
Journal:  World Psychiatry       Date:  2004-02       Impact factor: 49.548

2.  Disorganization and reality distortion in schizophrenia: a meta-analysis of the relationship between positive symptoms and neurocognitive deficits.

Authors:  Joseph Ventura; April D Thames; Rachel C Wood; Lisa H Guzik; Gerhard S Hellemann
Journal:  Schizophr Res       Date:  2010-06-25       Impact factor: 4.939

Review 3.  Endophenotypes in schizophrenia: a selective review.

Authors:  Allyssa J Allen; Mélina E Griss; Bradley S Folley; Keith A Hawkins; Godfrey D Pearlson
Journal:  Schizophr Res       Date:  2009-02-15       Impact factor: 4.939

4.  Effect of methamphetamine dependence on everyday functional ability.

Authors:  Brook L Henry; Arpi Minassian; William Perry
Journal:  Addict Behav       Date:  2010-02-01       Impact factor: 3.913

5.  Task-switching in schizophrenia: active switching costs and passive carry-over effects in an antisaccade paradigm.

Authors:  Cathleen Greenzang; Dara S Manoach; Donald C Goff; Jason J S Barton
Journal:  Exp Brain Res       Date:  2007-05-08       Impact factor: 1.972

6.  Effects of ketamine on context-processing performance in monkeys: a new animal model of cognitive deficits in schizophrenia.

Authors:  Rachael K Blackman; Angus W Macdonald; Matthew V Chafee
Journal:  Neuropsychopharmacology       Date:  2013-05-10       Impact factor: 7.853

7.  Everyday functional ability across different phases of bipolar disorder.

Authors:  Brook L Henry; Arpi Minassian; William Perry
Journal:  Psychiatry Res       Date:  2013-05-02       Impact factor: 3.222

8.  Selective remediation of reversal learning deficits in the neurodevelopmental MAM model of schizophrenia by a novel mGlu5 positive allosteric modulator.

Authors:  Francois Gastambide; Marie-Caroline Cotel; Gary Gilmour; Michael J O'Neill; Trevor W Robbins; Mark D Tricklebank
Journal:  Neuropsychopharmacology       Date:  2011-11-30       Impact factor: 7.853

9.  Effect of methamphetamine dependence on inhibitory deficits in a novel human open-field paradigm.

Authors:  Brook L Henry; Arpi Minassian; Mandy van Rhenen; Jared W Young; Mark A Geyer; William Perry
Journal:  Psychopharmacology (Berl)       Date:  2011-01-29       Impact factor: 4.530

10.  Schizophrenia spectrum participants have reduced visual contrast sensitivity to chromatic (red/green) and luminance (light/dark) stimuli: new insights into information processing, visual channel function, and antipsychotic effects.

Authors:  Kristin S Cadenhead; Karen Dobkins; Jessica McGovern; Kathleen Shafer
Journal:  Front Psychol       Date:  2013-08-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.